Amarin Corporation plc (AMRN) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers – Other. The stock has been active on the tape, currently trading at $4.01, down from yesterday’s close by -0.99%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Amarin Corporation plc (AMRN) currently trades with a market capitalization of $1.10 Billion. That value represents a market adjusting for revenues that have been growing by 44.68 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$51.4 Million over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of -$0.05 on a per share basis this quarter. Perhaps, that suggests something about why 0.63% of the outstanding share supply is held by institutional investors.
Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, Amarin Corporation plc recorded a 52-week high of $4.47. It is now trading 0.46% off that level. The stock is trading $3.45 its 50-day moving average by -0.56%. The stock carved out a 52-week low down at $2.81.
In recent action, Amarin Corporation plc (AMRN) has made a move of +22.63% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 19.03, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 4.78% with $149.51 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of AMRN.